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Abstract. 
 
FGF regulates both cell migration and prolif-
eration by receptor-dependent induction of immediate-
early gene expression and tyrosine phosphorylation of 
intracellular polypeptides. Because little is known 
about the disparate nature of intracellular signaling 
pathways, which are able to discriminate between cell 
migration and proliferation, we used a washout strategy 
to examine the relationship between immediate-early 
gene expression and tyrosine phosphorylation with re-
spect to the potential of cells either to migrate or to ini-
tiate DNA synthesis in response to FGF-1. We demon-
strate that transient exposure to FGF-1 results in a 
significant decrease in Fos transcript expression and a 
decrease in tyrosine phosphorylation of the FGFR-1, 
p42
 
mapk
 
, and p44
 
mapk
 
. Consistent with these biochemical 
effects, we demonstrate that attenuation in the level of 
DNA synthesis such that a 1.5-h withdrawal is sufficient 
to return the population to a state similar to quiescence. 
In contrast, the level of Myc mRNA, the activity of Src, 
the tyrosine phosphorylation of cortactin, and the FGF-
1–induced redistribution of cortactin and F-actin were 
unaffected by transient FGF-1 stimulation. These bio-
chemical responses are consistent with an implied un-
compromised migratory potential of the cells in re-
sponse to growth factor withdrawal. These results 
suggest a correlation between Fos expression and the 
mitogen-activated protein kinase pathway with initia-
tion of DNA synthesis and a correlation between high 
levels of Myc mRNA and Src kinase activity with the 
regulation of cell migration.
 
P
 
olypeptide
 
 growth factors are well-described as ini-
tiators of both cell migration and growth in vitro
through their ability to activate intracellular signal-
ing pathways. A number of polypeptides have been classi-
fied as intracellular signaling molecules; these include phos-
pholipase C-
 
g
 
 (6, 50), the GTPase-activating protein for ras
(51), the p85 subunit of phosphatidylinositol-3-kinase (17,
55), Src-like tyrosine kinases (45), STAT-kinases (14, 32),
mitogen-activated protein (MAP)
 
1
 
 kinases (61), and the Raf
proto-oncoprotein (58). However, the biochemical events
during G
 
1
 
 that lead to cytoskeleton alterations and spe-
cific-gene expression are not well-defined. Moreover, it is not
known what mechanism(s) determine whether a cell will
migrate and/or proliferate in response to a growth factor.
FGF-1 and FGF-2 are the prototype members of a large
family of related genes that regulate such important bio-
logical processes as differentiation, embryogenesis, neuro-
genesis, and angiogenesis, and are potent inducers of cell
migration and DNA synthesis in ectoderm- and mesoderm-
derived cell types (7, 22). While FGF-1 lacks a classical sig-
nal sequence to direct its export through the conventional
endoplasmic reticulum–Golgi pathway, it is released in re-
sponse to stress (38). FGF-1 release is important since it is
the interaction between the mitogen and the FGF receptor
(R)-1 on the surface of target cells that is essential to induce
intracellular signaling and DNA synthesis (18, 69, 73).
Although the mechanism of FGF-induced signal trans-
duction is not well-defined, FGF causes rapid FGFR
dimer formation at the cell surface, resulting in phos-
phorylation of intracellular polypeptides, including phos-
pholipase C-
 
g
 
 (6, 50), p90/FRS2 (19, 44), MAP kinases
(65), and Shc (65) as well as autophosphorylation of the
FGF receptor (19, 71). Additionally, FGF-1 induces tyrosine
phosphorylation of Src (74) during the entire G
 
1
 
 period,
which results in tyrosine phosphorylation of the F-actin–
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MAPK, mitogen-activated protein kinase; ODC, ornithine decarboxylase. 
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binding protein cortactin (72), a protein originally charac-
terized as the major substrate for v-Src (68). Exogenous
FGF-1 also upregulates transcription of immediate-early
genes (8), and activates a FGFR-1–mediated pathway re-
sulting in FGF-1 translocation from the cell surface to the
nucleus during the entire G
 
1
 
 period (71). FGFR-1 also
trafficks to a perinuclear locale during this time, and the
first immunoglobulin-like loop in FGFR-1 is responsible
for this event (57). Furthermore, removing FGF-1 from
Balb/c 3T3 cells during the mid-to-late G
 
1
 
 phase (10 h) re-
sults in significant attenuation in the level of DNA synthe-
sis as well as in translocation of exogenous FGF-1 and
FGFR-1 from the cell surface to nuclear and perinuclear
locales (69, 73).
Because the FGF-1 nuclear translocation events corre-
late with FGF-1–induced tyrosine phosphorylation during
the entire G
 
1
 
 period, and because removing exogenous
FGF-1 attenuates DNA synthesis induction, we became
interested in the plasticity of FGF-1–induced signaling
during this period. We examined the effects of transient
FGF-1 exposure on FGF-1–induced tyrosine phosphoryla-
tion and immediate-early gene expression as they relate to
the ability of cells to transition from G
 
0
 
 to the S phase of
the cell cycle, or to the ability of cells to migrate. Removal
of FGF-1 is accompanied by dephosphorylation of FGFR-1,
p90, p42
 
mapk
 
, and p44
 
mapk
 
, all of which are specifically
phosphorylated in response to exogenous FGF-1, and by a
significant decrease in Fos transcription. Consistent with
reversal of these biochemical responses, transient FGF-1
stimulation fails to result in maximal induction of DNA
synthesis.
 
 
 
In contrast, transient exposure of the cells to
FGF-1 results in continuous activation of Src, tyrosine
phosphorylation of cortactin, redistribution of F-actin and
cortactin to the cell periphery, and expression of both Myc
and ODC throughout the withdrawal period, correlating
with an uncompromised migratory potential of the cells.
The migratory potential of the cells in response to FGF-1
is severely compromised in the presence of a Myc inhibi-
tor. These results suggest that the constant presence of ex-
ogenous FGF-1 is required during the entire G
 
1
 
 period in
order to sustain Fos expression and tyrosine phosphoryla-
tion of FGFR-1, p42
 
mapk
 
, and p44
 
mapk
 
, and to achieve max-
imal DNA synthesis, whereas sustained activation of the
Src pathway, cytoskeletal reorganization, expression of
Myc and ODC, and cell migration only require transient
exposure to the growth factor.
 
Materials and Methods
 
Cell Culture and DNA Synthesis Assays
 
Swiss 3T3 cells and Balb/c 3T3 cells (American Type Culture Collection,
Rockville, MD) were maintained in DMEM (HyClone Laboratories Inc.,
Logan, UT) supplemented with 10% (vol/vol) calf serum (HyClone Labo-
ratories Inc.) and antibiotics (GIBCO BRL, Gaithersburg, MD). Cellular
quiescence was achieved by exposing confluent populations to a serum-
free hormone-defined medium (21) containing 10 
 
m
 
g/ml of insulin (DMI)
for 48 h as previously described (71). The cells were stimulated by adding
5–10 ng/ml recombinant human FGF-1 (37) and 10 
 
m
 
g/ml heparin (Sigma
Chemical Co., St. Louis, MO).
The transient effects of FGF-1 on Swiss 3T3 cells were determined by
incubating quiescent monolayers with FGF-1 for 3 h, removing the cell
culture medium, and washing the monolayer three times with DMEM
containing 10 
 
m
 
g/ml heparin. The monolayer was then supplemented with
DMI alone for 0.5, 1.5, or 3 h, and was further restimulated with 5 ng/ml
FGF-1 and 10 
 
m
 
g/ml heparin. The level of DNA synthesis was quantitated
in four to six independent samples by incorporating [
 
3
 
H]thymidine (0.5
 
m
 
Ci/ml, 20 Ci/mmol; Amersham Corp., Arlington Heights, IL) as previ-
ously described (70) by 20 min of pulse labeling 13, 15, 17, 19, 21, and 23 h
after restimulation.
 
Migration Assays
 
Migration of Balb/c 3T3 cells upon FGF-1 stimulation was determined us-
ing an in vitro model of wound repair as previously described (60). Balb/c
3T3 cells were used in this study since Swiss 3T3 cells exhibited a high
level of endogenous migration in the absence of FGF-1. In brief, confluent
monolayers of Balb/c 3T3 cells were made quiescent in DMI for 48 h. The
monolayers were then scraped with a razor blade, and cellular debris was
removed by washing with DMEM containing 10 
 
m
 
g/ml heparin. The
monolayers were incubated in DMI containing FGF-1 (10 ng/ml) and hep-
arin (10 
 
m
 
g/ml) for the times indicated. In the case of transient conditions,
monolayers were incubated in DMI containing FGF-1 and heparin for 3 h,
washed with DMEM containing heparin, and then incubated for 1.5 or 3 h
in DMI alone before further supplementation with FGF-1 and heparin.
For the delayed conditions, monolayers were incubated in DMI for 4.5 or
6 h, respectively, before FGF-1 stimulation. For the short stimulation,
monolayers were stimulated with FGF-1 for 3 or 6 h, washed with DMEM
containing heparin, and then incubated in DMI for the duration of the ex-
periment. The migration of the transient, delayed, and short-stimulated
populations were compared with the migration of cells treated continu-
ously with FGF-1. In all instances, cell migration was halted 22 h after
scraping when the cells were fixed with 25% acetic acid/75% methanol
and stained with hematoxylin. The number of cells migrating into the de-
nuded area was determined by counting using a light microscope under
100
 
3
 
 magnification with a grid. Each condition was examined in duplicate
with five representative fields for each plate being counted.
To measure the effect of the c-Myc inhibitor, FR901228 (64) on FGF-
1–induced Balb/c migration, confluent monolayers of cells were made qui-
escent for 24–48 h, and an area of cells was denuded with a razor blade
and was stimulated with 10 ng/ml FGF-1 and 10 
 
m
 
g/ml heparin in the pres-
ence of 2.5 ng/ml FR901228 as described above. Monolayers were either con-
stantly stimulated with FGF-1 for 22 h, or were transiently stimulated with
FGF-1 for 3 h, washed with DMEM containing heparin, and then incubated in
DMI for 3 h followed by restimulation with FGF-1 for the duration of the exper-
iment. Unstimulated cells were used as a control. For comparison, each popula-
tion was stimulated with FGF-1 in the absence of the inhibitor.
 
Phosphotyrosine Immunoblot Analysis
 
SDS-PAGE was performed as previously described (71). Confluent
monolayers of Swiss 3T3 cells were used to prepare cell lysates for immu-
noblot analysis. Cells were washed with cold PBS, scraped in cold PBS
containing 1 mM sodium vanadate, and collected by centrifugation. Cell
pellets were lysed in 0.5 ml of cold lysis buffer (20 mM Tris, pH 7.5, con-
taining 300 mM sucrose, 60 mM KCl, 15 mM NaCl, 5% (vol/vol) glycerol,
2 mM EDTA, 1% (vol/vol) Triton X-100, 1 mM PMSF, 2 mg/ml aprotinin,
2 mg/ml leupeptin, 0.2% (vol/vol) deoxycholate, and 1 mM sodium vana-
date, and the lysate was clarified by centrifugation at 4
 
8
 
C. The cytosol was
mixed with an equal volume of SDS-PAGE sample buffer, and was
heated at 95
 
8
 
C for 10 min. Equal protein concentrations of cytosol lysate
were subjected to 7.5% (wt/vol) SDS-PAGE, transferred to nitrocellulose
membranes (19), and blotted with an antiphosphotyrosine monoclonal an-
tibody (Upstate Biotechnology Inc., Lake Placid, NY). Phosphorylated
proteins were visualized using a horseradish peroxidase–conjugated rabbit
antibody against mouse IgG (Bio-Rad Laboratories, Hercules, CA) and
the enhanced chemiluminescence detection system (Amersham Corp.,
Arlington Heights, IL).
Tyrosine phosphorylation of FGFR-1 was determined by immunopre-
cipitation with affinity-purified polyclonal rabbit antibodies against
FGFR-1 that had been raised against a synthetic peptide whose sequence
is at the carboxy terminus of FGFR-1 (20, 71). Tyrosine phosphorylation
of p44
 
mapk
 
 and/or p42
 
mapk
 
 was determined by immunoprecipitation with
rabbit polyclonal antibodies (aERK-1 and aERK-2, respectively; Santa
Cruz Biotechnology, Santa Cruz, CA). Tyrosine phosphorylation of cort-
actin was determined by immunoprecipitation with polyclonal rabbit anti-
bodies against cortactin that had been raised against a peptide corre-
sponding to residues 343–362 in murine cortactin (72). Cells were lysed as
described above, and cytosolic lysates were rotated at 4
 
8
 
C for 1 h with ap-
propriate antibodies followed by the addition of protein A Sepharose
(Pharmacia Biotech, Inc., Piscataway, NJ) and further rotation at 4
 
8
 
C for 
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1  h. The antibody complexes were washed three times with the lysis
buffer, and immunoprecipitated proteins were eluted in 50 ml SDS-
PAGE sample buffer (46), resolved by 7.5% (wt/vol) or 9% (wt/vol) SDS-
PAGE, and immunoblotted with an antiphosphotyrosine monoclonal an-
tibody as described above.
 
In Vitro Kinase Assays
 
MAP kinase activity was determined by immunoprecipitation of lysates
with aERK-1 and aERK-2 (Santa Cruz Biotechnology) and immobilization
of protein–antibody complexes on protein A-Sepharose. Cells were lysed
and immunoprecipitated as described above. After immunoprecipitation,
the antibody complexes were washed three times with the lysis buffer
and once with kinase buffer (40 mM Hepes, pH 7.4, containing 100 mM
 
b
 
-glycerophosphate, 2 mM EDTA, 10 mM MgCl
 
2
 
, 1 mM DTT, 1 mM
Na
 
3
 
VO
 
4
 
), and were subsequently incubated in 40 
 
m
 
l of kinase buffer con-
taining 10 
 
m
 
Ci of [
 
g
 
-
 
32
 
P]ATP and 5 
 
m
 
g mylein basic protein at room tem-
perature for 30 min. The phosphorylated proteins were resolved by 12.5%
(wt/vol) SDS-PAGE, transferred to nitrocellulose, and visualized by auto-
radiography. Subsequently, immunoblot analysis was performed using the
ERK-1 antibody (Santa Cruz Biotechnology).
The Src kinase activity was determined by immunoprecipitation with
monoclonal Src antibody 327 (52) and goat anti–mouse immunoglobulin
G antibody (Pierce Chemical Co., Rockford, IL) immobilized on protein
A-Sepharose. Cells were lysed and immunoprecipitated as described
above. After immunoprecipitation, the antibody complexes were washed
three times with the lysis buffer and once with kinase buffer (30 mM Tris,
pH 7.4, containing 10 mM MnCl
 
2
 
), and were subsequently incubated in 50 
 
m
 
l
of kinase buffer containing 10 
 
m
 
Ci of [
 
g
 
-
 
32
 
P]ATP and 2 
 
m
 
g acid-denatured
enolase (Sigma Chemical Co.) at room temperature for 10 min. The phos-
phorylated proteins were resolved by 9% (wt/vol) SDS-PAGE, trans-
ferred to nitrocellulose, and visualized by autoradiography. Subsequently,
immunoblot analysis was performed using the Src-2 antibody (Santa Cruz
Biotechnology) as previously described (25).
 
RNA Extraction and Analysis
 
Total RNA was isolated by the guanidinium isothyocyanate procedure as
previously described (24). The RNA was electrophoresed on an 0.8% (wt/
vol) agarose gel containing 2.2 M formaldehyde, capillary-blotted onto ny-
lon membrane filters (Zeta-Probe; Bio-Rad Laboratories), and hybridized
to 
 
32
 
P-labeled DNA probes at 65
 
8
 
C for 20 h. Filters were washed at high
stringency and exposed to Kodak XAR films (Eastman Kodak Co., Roch-
ester, NY). The Fos probe was an 1.8-kb EcoRI-SalI fragment from the
murine Fos genomic clone containing the second, third, and a portion of
the fourth Fos exon (49). The ornithine decarboxylase (ODC) probe was
a 1.3-kb PstI fragment from the murine ODC cDNA (American Type
Culture Collection; reference 3). The Myc probe was a 1.4-kb SstI frag-
ment from the human cDNA (1).
 
Nuclear Run-on Assay
 
Nuclei from confluent monolayers of Swiss 3T3 cells were isolated and
frozen in two aliquots at 
 
2
 
80
 
8
 
C as previously described (29). Nuclear run-
on assays were performed by incubating the thawed nuclei for 30 min at
30
 
8
 
C with 100 
 
m
 
Ci [
 
32
 
P]UTP, and nascent RNA transcripts were isolated
as previously described (33). Plasmid vector (negative control) and plas-
mid cDNAs (5 
 
m
 
g of each) were linearized, denatured, and applied to ny-
lon membrane filters (Zeta-Probe; Bio-Rad Laboratories) using a slot blot
apparatus and cross-linked by UV irradiation. Filters containing DNA
probes were prehybridized for at least 2 h at 65
 
8
 
C, and were hybridized in
3 ml of hybridization buffer (33) containing 3 
 
3 
 
10
 
7
 
 cpm of [
 
32
 
P]labeled
RNA at 65
 
8
 
C for 3 d. Filters were washed at high stringency, dried, and
exposed to x-ray film at 
 
2
 
80
 
8
 
C. Densitometric analysis was performed us-
ing the Lynx 4000 workstation, and values were normalized to the glycer-
aldehyde-3-phosphate dehydrogenase 
 
(
 
GAPDH) value. The GAPDH
plasmid contained a 1.3-kb human cDNA.
 
Fluorescence Microscopy 
 
Swiss 3T3 cells were plated on glass coverslips coated with fibronectin,
and were then processed for washout experiments. Cell fixation was per-
formed using 3% paraformaldehyde in PBS with incubation at room tem-
perature for 15 min. For cortactin staining, fixed cell monolayers were
washed with PBS and blocked with PBS containing 5% BSA, 0.1% Triton
X-100, 0.1% Tween 20, and 0.1% NaN
 
3
 
 for 1 h. The monolayer was
washed with PBS three times, incubated with anticortactin antiserum (72),
diluted 1:50 in blocking buffer for 1 h, washed three times with PBS, and
incubated with CY3-conjugated anti–rabbit IgG antibodies (Sigma Chem-
ical Co.) diluted 1:500 in blocking buffer for 0.5 h. The monolayer was
washed with PBS three times and embedded in 50% glycerol with phe-
nylenediamine. For F-actin staining, the monolayer was blocked, incu-
bated with 0.1 
 
m
 
g/ml TRITC-conjugated phalloidin (Aldrich Chemical
Co., Milwaukee, WI), and embedded as described above. The cells were
photographed with a fluorescence microscope (Olympus Corp., Lake Suc-
cess, NY) at 200
 
3
 
 and 600
 
3
 
.
 
Results
 
The Kinetics of FGF-1 Removal and Initiation of
DNA Synthesis
 
Prior studies from our laboratory have demonstrated that
the presence of exogenous FGF-1 is required during the
entire G
 
1
 
 period to achieve maximal levels of DNA synthe-
sis (71). Indeed, exposure of quiescent Swiss 3T3 cells to
exogenous FGF-1 followed by FGF-1 withdrawal and sup-
plementation with DMI (short stimulation) results in in-
duction of a low level of DNA synthesis (Fig. 1). To analyze
further the effects of transient exposure of exogenous
FGF-1 on Swiss 3T3 cells early in G
 
1
 
, we used heparin to re-
move FGF-1 from the cell culture environment since prior
efforts have demonstrated that heparin is able to reduce
nonspecific binding of FGF-1 significantly (71). In these
experiments, quiescent Swiss 3T3 cell monolayers were in-
cubated with FGF-1 for 3 h, the cell culture medium was
removed, and the monolayer was washed with DMEM
containing heparin. The monolayer was then supplemented
with DMI alone for either 0.5 or 1.5 h. After incubation in
the absence of growth factor, the monolayer was restimu-
lated with FGF-1, and at various time points the level of
DNA synthesis was determined (Fig. 1 
 
A
 
). This population
was designated the transiently stimulated population. For
comparison, at the time of restimulation, quiescent Swiss
3T3 cells were exposed to exogenous FGF-1 and desig-
nated the delayed population. As shown in Fig. 1 
 
B
 
, the in-
crease in DNA synthesis in cells that were interrupted in
their exposure to FGF-1 for 0.5 h was less than the levels
of DNA synthesis achieved in the continuously stimulated
cultures. However, this brief interruption in exposure of
Swiss 3T3 cells to FGF-1 yielded a higher level of DNA
synthesis than that observed in the delayed population. In
contrast, increasing the interruption time of exposure to
exogenous FGF-1 from 0.5 to 1.5 h resulted in a level of
DNA synthesis in the transient population that was similar
to that observed in the delayed population (Fig. 1 
 
C
 
).
We have also observed that at the early time points (Fig.
1 
 
C
 
; 13–17 h), the transiently stimulated population dem-
onstrated a small increase in the level of DNA synthesis
when compared with the delayed-stimulation population.
This relatively small increase may have resulted from the
initial 3-h period of exposure to exogenous FGF-1, since a
low level of DNA synthesis was also exhibited by the
short-stimulated population that is exposed to exogenous
FGF-1 for only 3 h (Fig. 1 
 
C
 
; compare 
 
filled diamonds
 
 with
 
open squares
 
). Thus, we suggest that the difference in the
level of DNA synthesis between the transiently-stimulated
and delayed-stimulated populations during the early time
points (13–17 h) may not be significant since it is similar to
the low levels of [
 
3
 
H]thymidine incorporation exhibited by 
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the short-stimulated population (Fig. 1 
 
C
 
). More impor-
tantly, however, the levels of DNA synthesis exhibited at
the later time points (Fig. 1 
 
C
 
; 19–23 h) by the transiently
and delayed-stimulated populations are similar (Fig. 1 
 
C
 
;
compare 
 
filled diamonds 
 
with 
 
open diamonds
 
), suggesting
that a 3-h period of exposure to exogenous FGF-1 fol-
lowed by a withdrawal period of 1.5 h is sufficient to gen-
erate a population of cells that is similar to a population
that has not been exposed to exogenous FGF-1.
 
Correlation of Gene Expression with FGF-1 
Withdrawal in Swiss 3T3 Cells
 
Because expression of various cell cycle–specific genes has
been correlated with DNA synthesis and cell growth, we
examined the effects of FGF-1 withdrawal on expression
of the immediate-early response genes Myc and Fos, and the
early-to-mid response gene ornithine decarboxylase (ODC).
RNA was extracted from Swiss 3T3 cells at quiescence af-
ter a 1-, 3-, and 6-h exposure to FGF-1, or from popula-
tions that were transiently induced with FGF-1 and subse-
quently subjected to FGF-1 removal by a heparin wash.
Northern blot analysis demonstrated that the steady-state
levels of the Fos, Myc, and ODC transcripts were readily in-
duced by FGF-1 after stimulation for 1, 3, or 6 h (Fig. 2).
The withdrawal of FGF-1 for 0.5 h did not significantly
change the steady-state level of these transcripts. However,
removal of exogenous FGF-1 for 1.5 or 3 h resulted in a dra-
matic decrease in the steady-state level of the Fos transcript,
resulting in similar levels to those detected in quiescent
cells (Fig. 2 
 
A
 
). Interestingly, restimulation of the cell pop-
ulation with FGF-1 for 1 h after the 3-h withdrawal period
resulted in reinduction of the Fos transcript (Fig. 2 
 
A
 
).
In contrast, removing FGF-1 for 0.5, 1.5, or 3 h did not
significantly decrease the level of either the Myc or ODC
transcripts (Fig. 2, 
 
B
 
 and 
 
C
 
). Thus, the decrease in the
steady-state level of the Fos transcript after a 1.5-h with-
drawal of FGF-1 correlates with a decrease in the level of
DNA synthesis (Fig. 1 
 
C
 
), whereas the continual high
steady-state levels of Myc and ODC mRNA after a 1.5- or
a 3-h withdrawal of FGF-1 are not sufficient to promote
progression into the S phase of the cell cycle.
To determine whether downregulation of the Fos tran-
script in response to FGF-1 removal is regulated at the
level of transcriptional initiation, a nuclear run-on analysis
was performed. Nuclei were isolated from Swiss 3T3 cells
that were exposed to FGF-1 for either 1 or 3 h. An in-
crease in the rate of Fos transcription was observed as
compared with the level of Fos transcription from nuclei
derived from quiescent cells (Fig. 3). Nuclei isolated from
cells that were transiently exposed to FGF-1 for 3 h, fol-
lowed by a 3-h removal of the mitogen, demonstrated that
the level of transcriptional initiation was less than that ob-
served in quiescent cells (Fig. 3). Densitometric measure-
Figure 1. Dynamics of DNA
synthesis in Swiss 3T3 cells re-
stimulated with FGF-1 after re-
moving FGF-1. (A) Schematic
diagrams of the experiments us-
ing confluent Swiss 3T3 cells
that were made quiescent by in-
cubating for 48 h in a serum-free
DMI supplemented with 10 mg/
ml insulin. Quiescent cells were
stimulated for 3 h with FGF-1 (5
ng/ml) and heparin (10 mg/ml),
culture medium was removed,
and the monolayer was washed
three times with DMEM con-
taining heparin. The cells were
incubated for either 0.5 or 1.5 h
in DMI alone, and were restimu-
lated with FGF-1 and heparin
(transient stimulation). Three
types of controls were also per-
formed: (a) constant stimula-
tion, FGF-1 was not removed;
(b) short stimulation, cells were
stimulated with FGF-1 for 3 h,
washed with heparin, and incu-
bated in DMI without FGF-1;
and (c) delayed stimulation,
FGF-1 was added to quiescent
cells simultaneously with restim-
ulation of the cells that were
undergoing the transient stimu-
lation. DNA synthesis was mon-
itored using [3H]thymidine incorporation 13–21 h after restimulation. (B) Restimulation with FGF-1 and heparin after a 0.5-h interrup-
tion with a heparin wash. [3H]thymidine incorporation (6 SD) as a function of time after restimulation with constant stimulation (j),
short stimulation (h), transient stimulation (r), and delayed stimulation (e) of Swiss 3T3 cell populations. (C) Restimulation with
FGF-1 and heparin after a 1.5-h interruption with a heparin wash. Description is identical to that described in B. 
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ments determined that a 2.5-fold decrease in Fos transcrip-
tional initiation was observed in cells transiently exposed
to FGF-1 as compared with cells that were continuously stim-
ulated with FGF-1 for 6 h. These data suggest that Fos tran-
script inhibition occurs at least partially at the level of tran-
scriptional initiation. A 1-h restimulation of the cell
population transiently exposed to FGF-1 resulted in only a
2.8-fold increase in Fos transcription as compared with qui-
escent populations, whereas the populations exposed to
FGF-1 for 1 h resulted in a 3.4-fold increase. However, the
rate of Fos transcription in the 1 h–restimulated populations
was similar to the rate of transcription in the nuclei that
were continuously exposed to FGF-1 for 6 h. These data ar-
gue that the high steady-state level of the Fos transcript after
a 1-h restimulation observed by Northern blot analysis
(Fig. 2
 
 A
 
) may be due to both transcriptional and posttran-
scriptional events. In contrast, transient exposure to FGF-1
did not significantly affect ODC transcriptional initiation,
where densitometry determined a relative amount of 0.76 for
the transiently stimulated population and a relative amount
of 0.79 for the 6-h constantly stimulated population.
Interestingly, transcriptional initiation of the Myc tran-
script did not occur after a 6-h FGF-1 stimulation or after
exposure to FGF-1 for 3 h followed by a 3-h withdrawal
(Fig. 3). This result suggests that the high level of Myc
transcript observed in these populations by Northern blot
analysis (Fig. 2 B) was likely due to mRNA stability. Thus,
these data suggest that the steady-state level of Fos tran-
script is sensitive to the continual presence of FGF-1, and
that the growth factor is required to activate transcrip-
tional initiation of the Fos transcript. Furthermore, unlike
the levels of the Fos transcripts, the steady-state Myc
mRNA levels were not affected by transient exposure to
FGF-1. Based on the nuclear run-on analysis, this result is
most likely due to mRNA stability.
Additionally, to determine the cell cycle progression of the
transiently stimulated population, the cells were examined
for the presence of cyclin D1, a marker for the cells’ progres-
sion into the G1 phase of the cell cycle (42, 69). Detectable
levels of cyclin D1 were not observed until after the cells
were exposed to FGF-1 for 4.5 h. A reduction of cyclin D1
(data not shown) was observed in the population that was
stimulated with FGF-1 for 3 h followed by a 3-h withdrawal
as compared with the level of cyclin D1 observed after a 6-h
FGF-1 stimulation. These results suggest that a 3-h stimula-
tion followed by a 3-h withdrawal period of FGF-1 halts the
progression of the cells into the G1 phase of the cell cycle.
The Kinase Activity of MAPK, but Not Src, is Sensitive 
to FGF-1 Withdrawal 
Analysis of Balb/c 3T3 cells has demonstrated FGF-1–depen-
dent tyrosine phosphorylation events throughout the en-
tire G1 transition period (71). To determine the influence
of transient exposure to FGF-1 on modification of phos-
Figure 2. The steady-state mRNA levels of FGF-1–induced
genes after FGF-1 removal. RNA was extracted from Swiss 3T3
cells either at quiescence, after a 1-, 3-, or 6-h FGF-1 stimulation,
or from populations that were transiently stimulated with FGF-1
(exposed to FGF-1 for 3 h, followed by a heparin wash and sup-
plemented with DMI for 0.5, 1.5, or 3 h, or supplemented with
DMI for 3 h and then reexposed to FGF-1 for 1 h). Northern blot
analysis was performed as described in experimental procedures.
Expression of the (A) Fos transcript (above), of the (B) Myc tran-
script (above), or of the (C) ODC transcript (above) with corre-
sponding ethidium bromide–stained 18S rRNA (below) is shown.
Figure 3. Nuclear run-on analysis of transcriptional events after
the removal of FGF-1. Nuclei were isolated from quiescent Swiss
3T3 cells that had been stimulated with FGF-1 for 0, 1, 3, and 6 h;
had been stimulated with FGF-1 for 3 h, washed with heparin and
harvested 3 h after the heparin wash; or had been stimulated with
FGF-1 for 3 h, washed with heparin, incubated in DMI without
FGF-1 for 3 h, and restimulated with FGF-1 for 1 h. 32P-labeled
RNA transcripts (3 3 107 cpm) were hybridized to 5 mg of human
Myc, human Fos, murine ODC, and human GAPDH cDNA, and
5 mg of pUC9 DNA that had been linearized and blotted onto ny-
lon membrane filters as described in Materials and Methods.The Journal of Cell Biology, Volume 141, 1998 1652
photyrosine-containing polypeptides, cell lysates were pre-
pared at various times of exposure or removal of FGF-1,
and were evaluated by immunoblot analysis. As shown in
Fig. 4 A, we observed two distinct patterns of tyrosine
phosphorylation. Stimulating cells for 3 or 6 h resulted in
the appearance of a 90-kD protein (p90) and the disap-
pearance of a 70-kD protein (p70) as a phosphotyrosyl-
containing polypeptide. The cells stimulated for 3 h fol-
lowed by a 0.5-h withdrawal of FGF-1 did not significantly
change the levels of tyrosine phosphorylation, as com-
pared with lysates prepared from cells that were stimu-
lated with FGF-1 for 3 h (Fig. 4 A). However, extending
the withdrawal period to 1.5 or 3 h resulted in a dramatic
decrease in tyrosine phosphorylation of p90. Moreover,
the reappearance of p70 as a phosphotyrosyl-containing
polypeptide was also observed (Fig. 4 A). Thus, a 3-h with-
drawal of FGF-1 from the cell culture population is suffi-
cient to return the level of tyrosine phosphorylation to a
level similar to that observed in unstimulated cells. Fur-
thermore, restimulating the cells with FGF-1 after the 3-h
withdrawal results in a pattern of tyrosine phosphorylation
similar to that observed in the 3- and 6-h FGF-1–stimulated
population.
FGF-1 induces tyrosine phosphorylation of FGFR-1
during the entire G1 period (74). To examine the effects of
transient exposure of FGF-1 on the levels of the tyrosine
phosphorylation of the receptor, immunoprecipitation and
immunoblot analysis were used. Quiescent Balb/c 3T3 or
Swiss 3T3 cells were either exposed to FGF-1 for 3 and 6 h,
or cells were induced with FGF-1 for 3 h, and exogenous
FGF-1 was removed with a heparin wash (Fig. 4 B). The
level of tyrosine phosphorylation of FGFR-1 is very low in
quiescent cells, whereas stimulation of the cells with FGF-1
for either 3 or 6 h resulted in a significant increase in ty-
rosine phosphorylation of both the p130 and p145 forms of
FGFR-1. Removing exogenous FGF-1 for 0.5 h did not in-
fluence the level of FGFR-1 tyrosine phosphorylation.
However, a 1.5- or a 3-h withdrawal of FGF-1 significantly
decreased tyrosine phosphorylation of FGFR-1 to a level
that is similar to that observed in quiescent cell lysates.
Figure 4. (A) Immunoblot analysis of tyrosine phosphorylation in Swiss 3T3 cells after removal of FGF-1. Quiescent Swiss 3T3 cells
were exposed to FGF-1 for 0, 3, or 6 h; stimulated with FGF-1 for 3 h, and washed with heparin and harvested 0.5, 1.5, or 3 h after the he-
parin wash; or were stimulated with FGF-1 for 3 h, washed with heparin, incubated in DMI without FGF-1 for 3 h, and then restimu-
lated with FGF-1 for 1 h. The cells were harvested, and cytosolic lysates were prepared as described in Materials and Methods. Lysates
were analyzed by 7.5% (wt/vol) SDS-PAGE, transferred to nitrocellulose membranes, and probed with an antiphosphotyrosine anti-
body as described (19). The positions of the p90 and p80 bands are indicated by closed arrows, and the p70 band is indicated by an open
arrow. (B) Tyrosine phosphorylation of FGFR-1 in response to transient exposure to FGF-1. Quiescent Swiss 3T3 cells were stimulated,
washed, and restimulated with FGF-1 in a manner identical to that described above. Cell lysates were immunoprecipitated with a rabbit
anti-FGFR-1 polyclonal antibody and subjected to immunoblot analysis (7.5% [wt/vol] SDS-PAGE) with an antiphosphotyrosine anti-
body as described in Materials and Methods. The position of p130/p145 FGFR-1 polypeptides are indicated by closed arrows. (C) Ty-
rosine phosphorylation of p44mapk and p42mapk in response to transient exposure to FGF-1. Quiescent Swiss 3T3 cells were stimu-
lated, washed, and restimulated with FGF-1 in a manner identical to that described in Fig. 4 A. Cell lysates were immunoprecipitated
with a rabbit anti-ERK-1 polyclonal and rabbit anti-ERK-2 polyclonal antibodies, and were subjected to immunoblot analysis (9% [wt/
vol] SDS-PAGE) with an antiphosphotyrosine antibody as described in Materials and Methods. The positions of p44mapk (ERK-1) and
p42mapk (ERK-2) are indicated by closed arrows. (D) In vitro MAP kinase activity in response to transient exposure to FGF-1. Quies-
cent Swiss 3T3 cells were either stimulated with FGF-1 for 0, 3, 4.5, or 6 h, or were stimulated with FGF-1 for 3 h, washed with heparin,
and harvested 1.5 or 3 h after the heparin wash. Cell lysates were immunoprecipitated with anti-Erk-1 and/or anti-Erk-2, and an in vitro
kinase assay was performed using MBP as the substrate. The kinase reactions were analyzed by 12.5% (wt/vol) SDS-PAGE, transferred
to nitrocellulose membranes, and phosphorylated MBP was visualized by autoradiography. The position of MBP is indicated by a closed
arrow. Because the p44mapk band does not resolve away from the antibody band in the immunoblot, we used a different experiment in
which a similar trend was observed to quantitate these results: quiescence, 1.0; 3-h stimulation, 14.9; 4.5-h stimulation, 16.4; 3-h stimula-
tion followed by a 1.5-h withdrawal, 3.7; 3-h stimulation followed by a 3-h withdrawal, 2.0; and 6-h stimulation, 24.5. (E) The level of
p44mapk (ERK-1) and p42mapk (ERK-2) protein was visualized by immunoblot analysis with p44mapk (ERK-1) polyclonal antibodies.
The position of p44mapk and p42mapk is indicated by a closed arrow, and the position of IgG is indicated with an open arrow.LaVallee et al. Regulation of FGF-1–induced Cell Migration and Proliferation 1653
Restimulating the cells for 1 h after the 3-h withdrawal of
exogenous FGF-1 induced a prominent tyrosine phosphor-
ylation of FGFR-1 (Fig. 4 B).
Because many of the tyrosine phosphorylated substrates
induced by FGF-1 are known, we examined the effect of
transient FGF-1 exposure on these substrates. It has been
demonstrated that the interaction of the FGFR-1 with
FGF-1 leads to activation of the PLC-g and the Ras path-
ways; both of these pathways have been shown to contrib-
ute to MAP kinase activation (35). MAP kinases are ac-
tivated rapidly in response to numerous extracellular
response systems such as mitogens, neurotransmitters,
phorbol esters, and heat shock (56). Persistent activation
of MAP kinases throughout the G1 period has been shown
to be important for cells to transition into the S phase of
the cell cycle (47, 48). To investigate the effects of tran-
sient exposure of FGF-1 on activation of p44mapk and
p42mapk, we examined the levels of tyrosine phosphoryla-
tion by immunoprecipitation and immunoblot analysis
(Fig. 4 C). FGF-1 stimulation of cells results in increased
levels of tyrosine phosphorylation of both p44mapk and
p42mapk after a 3-, 4.5-, and 6-h exposure to FGF-1 (Fig. 4 C).
Removing exogenous FGF-1 for 1.5 or 3 h results in a sig-
nificant decrease in the level of tyrosine phosphorylation
of both p44mapk and p42mapk (Fig. 4 C). Consistent with the
phosphotyrosyl content of p44mapk and p42mapk, an in vitro
kinase assay demonstrated that p44mapk and p42mapk specif-
ically phosphorylated their substrate, MBP, in response to
FGF-1 stimulation for 3, 4.5, or 6 h (Fig. 4 D). However, if
the cell population was exposed to FGF-1 for 3 h followed
by a 1.5- or a 3-h withdrawal period, the MAP kinase ac-
tivity returns to the levels observed in the quiescent state
(Fig. 4 D), while the amount of the p44mapk and p42mapk
proteins remain similar (Fig. 4 E). Downregulation of the
MAP kinase activity is consistent with downregulation of
Fos mRNA in response to growth factor withdrawal, since
Fos is a target of the MAP kinase pathway (2), and inhibi-
tion of MAP kinase activity results in partial inhibition of
Fos (66).
FGF-1 has also been shown to induce tyrosine phos-
phorylation and activation of Src, which then tyrosine-
phosphorylates cortactin (74). Because the Src protein can
be phosphorylated on tyrosine residues in an inactive or
an active state (13, 54), we used an in vitro kinase assay to
determine the effects of transient FGF-1 exposure on Src
activity. An in vitro kinase assay in the presence of the Src
substrate enolase demonstrates that both the Src protein
and enolase are phosphorylated in response to FGF-1
(Fig. 5 A). Surprisingly, the level of Src kinase activity re-
mains the same when the growth factor is removed for 1.5
or 3 h. Densitometric scanning demonstrates that when
Src activity, represented by the level of enolase phosphor-
ylation, is normalized for the level of Src protein (Fig. 5
B), Src activity at 4.5 h is 4.0-fold higher than the activity
at quiescence, and Src activity after a 3-h stimulation fol-
lowed by a 1.5-h withdrawal is 3.6-fold higher than at qui-
escence. Persistent activation of Src, despite withdrawal of
growth factor, was observed in both Swiss 3T3 and Balb
Figure 5. (A) In vitro Src kinase
activity after the removal of
FGF-1. Quiescent Swiss 3T3
cells were either stimulated with
FGF-1 for 0, 3, 4.5, or 6 h; or
were stimulated with FGF-1 for
3 h, washed with heparin, and
harvested 1.5 or 3 h after the he-
parin wash. Cell lysates were im-
munoprecipitated with anti-
c-Src monoclonal antibody 327,
and an in vitro kinase assay was
performed using enolase as the
substrate. The kinase reactions
were analyzed by 9% (wt/vol)
SDS-PAGE, transferred to ni-
trocellulose membranes, and
phosphorylated Src and enolase
were visualized by autoradiogra-
phy. The position of Src is indi-
cated by a closed arrow, and the
position of enolase is indicated
by an open arrow. (B) The level
of Src protein was visualized by
immunoblot analysis with Src2
polyclonal antibodies. The posi-
tion of Src is indicated by a closed arrow, and the position of IgG is indicated by an open arrow. (C) Tyrosine phosphorylation of cortac-
tin (p80) in response to transient exposure to FGF-1. Quiescent Balb/c 3T3 cells were stimulated, washed, and restimulated with FGF-1
in a manner identical to that described in Fig. 5 A. Cell lysates were immunoprecipitated with rabbit anticortactin antibody 2719 and
subjected to immunoblot analysis (7.5% [wt/vol] SDS-PAGE) with an antiphosphotyrosine antibody as described in Materials and
Methods. The position of p80 is indicated by a closed arrow, and the position of IgG is indicated with an open arrow. (D) The level of
cortactin protein was visualized by immunoblot analysis with anticortactin polyclonal antibodies (72). The position of cortactin is indi-
cated by a closed arrow, and the position of IgG is indicated by an open arrow.The Journal of Cell Biology, Volume 141, 1998 1654
3T3 cells (data not shown). Consistent with the Src in vitro
kinase data, immunoprecipitation of the Src substrate
cortactin and subsequent immunoblot analysis, demon-
strates that the level of tyrosine phosphorylation of cortac-
tin is also not sensitive to withdrawal of FGF-1, and in-
creases despite FGF-1 withdrawal (Fig. 5 C).
The FGF-1-Induced Changes of the Actin Cytoskeleton 
are Maintained After FGF-1 Withdrawal 
Src plays a central role in regulating a variety of biological
processes that are associated with changes in the cellular
architecture. Therefore, we examined the different popu-
lations of cells for changes in F-actin and cortactin distri-
bution. We investigated whether the FGF-induced changes
in actin redistribution were sensitive to transient FGF-1
stimulation. FGF-1 stimulation for 3 or 6 h results in disap-
pearance of most of the bulky F-actin bundles and redistribu-
tion of the F-actin to the cell periphery (compare Fig. 6, A,
B, and D). Furthermore, in cells exposed to FGF-1 for 6 h,
formation of peripheral polarized stress fibers are readily
observed, suggesting that the cells are competent for migra-
tion. Since the transiently stimulated population exhibited
a similar distribution of F-actin and formation of peripheral
polarized stress fibers as observed in the 6-h FGF-1–stimu-
Figure 6. Fluorescence microscopy of actin and cortactin distribution upon differential FGF-1 stimulation. Quiescent and FGF-1–stimu-
lated Swiss 3T3 cell monolayers were processed for fluorescence microscopy as described in Materials and Methods. Quiescent cells (A,
E, and I), cells stimulated with FGF-1 for 3 h (B, F, and J), and cells stimulated with FGF-1 for 3 h followed by a 3-h withdrawal period
(C, G, and K), and cells stimulated with FGF-1 for 6 h (D, H, and L) were stained with TRITC-phalloidin (A–D) or with anticortactin
antibodies (E–L) and photographed with a fluorescence microscope. Bars: (A–H) 20 mm; (I–L) 15 mm.LaVallee et al. Regulation of FGF-1–induced Cell Migration and Proliferation 1655
lated population (compare Fig. 6, C and D), we suggest that
redistribution of F-actin is insensitive to FGF-1 withdrawal.
Cortactin has been demonstrated to be an F-actin–bind-
ing protein whose F-actin cross-linking activity is down-
regulated upon tyrosine phosphorylation (34). Staining
quiescent cells with anti-cortactin antibodies revealed that,
like F-actin, the protein was distributed throughout the cy-
toplasm (Fig. 6 E). At a higher magnification, cortactin-
positive fibers were readily visible (Fig. 6 I). Exposing the
cells to FGF-1 for 3 or 6 h resulted in partial redistribution
of cortactin to the cell periphery (Fig. 6, F and H) and dis-
appearance of the cortactin-positive fibers (Fig. 6, J and
L). Stimulation with exogenous FGF-1 for 3 h followed by
a 3-h withdrawal of the growth factor did not significantly
change the peripheral distribution of cortactin (Fig. 6, G
and K). Therefore, neither redistribution of F-actin and
cortactin nor tyrosine phosphorylation of cortactin require
the continual presence of FGF-1.
Withdrawal of FGF-1 Does Not Appear to Result in an 
Attenuation of Cell Migration 
We were surprised to find that Src activation was main-
tained despite the withdrawal of FGF-1, since Src has been
implicated in the regulation of intracellular signaling
events that result in proliferation (16, 63). However, acti-
vation of Src by dephosphorylating tyrosine 527 results in
redistribution of Src from the endosomal membranes to
focal adhesion sites (40). In addition, several Src sub-
strates are involved in regulating cellular architecture, and
have been implicated in cell attachment and migration (9,
28). Thus, the lack of an effect of transient FGF-1 expo-
sure on Src kinase activity and F-actin and cortactin redis-
tribution prompted us to investigate the migratory poten-
tial of the cells by using an in vitro wound repair model
(60). In these studies we were unable to use Swiss 3T3 cells
since these cells had a high basal level of migration in the
absence of FGF-1. Therefore, Balb/c 3T3 cells were used
to study the plasticity of FGF-1–induced migration. In this
regard, analysis of the phosphotyrosine immunoblots and
kinase activity of p44mapk/p42mapk and Src in the Balb/c 3T3
cell population were similar to those obtained with the
Swiss 3T3 cell population (data not shown). For the tran-
siently stimulated population, quiescent Balb/c 3T3 cells
were wounded and then exposed to FGF-1 for 3 h, the cell
culture medium was removed, and the monolayer was
washed with DMEM containing heparin. The monolayer
was supplemented with DMI alone for either 1.5 or 3 h,
and was restimulated with FGF-1 such that the total time
from the initial exposure of FGF-1 equaled 22 h. For com-
parison, cell monolayers were stimulated continuously
with FGF-1 for 22 h, and were designated the constantly
stimulated population. Furthermore, at the time that FGF-1
was added back into the transiently stimulated popula-
tions, cells designated the delayed population were ini-
tially exposed to FGF-1. As shown in Fig. 7 A, the con-
stantly stimulated population (22 h) exhibited a marked
increase in migration as compared with the population
that was not exposed to exogenous FGF-1. The transiently
stimulated population demonstrated no significant change
in their migratory potential as compared with the con-
stantly-stimulated population. In contrast, the monolayers
that were subjected to the delayed stimulation displayed a
reduced migratory potential as compared with the tran-
siently stimulated population (Fig. 7 A). These data sug-
gest that the migratory potential of the cell may not be af-
fected by withdrawal of FGF-1 for up to 3 h.
The relatively small difference in the migratory potential of
the transiently stimulated populations compared with the
constantly stimulated populations may be attributed to tech-
nical manipulations. If the constantly stimulated and tran-
siently stimulated populations were treated similarly such
that the constantly stimulated monolayer is exposed to FGF-1
for 3 h, the cells removed from the incubator, washed with
DMEM containing heparin, and then reexposed to FGF-1
for 19 h, we observed a variation in the migration of these
cells of 9.25% as compared with the cells constantly stimu-
lated with exogenous FGF-1 for 22 h. Similarly, a variation of
9.20% was observed between migration of the transiently
stimulated population and constantly stimulated populations
(data not shown), suggesting that these small differences
may be due to requisite technical manipulations of the cell
culture system. Furthermore, we have also observed by time-
lapse photography that migration of the Balb/c 3T3 cell pop-
ulation begins approximately after a 6–8-h stimulation with
FGF-1 (data not shown). Consistent with these results, cells
in the constant and the transiently stimulated populations
started their migration after an 8-h time period (data not
shown). Since this in vitro wound repair model may be sen-
sitive to the manipulations required to analyze the migra-
tory phenotype, we suggest that the migration data in combi-
nation with the biochemical data correlating the insensitive
nature of Src kinase activity and F-actin and cortactin redis-
tribution to FGF-1 withdrawal imply that the migratory po-
tential of the these cells is not sensitive to FGF-1 withdrawal.
Recently, Boyer et al. demonstrated that Src kinases play a
role in epithelial cell dispersion in response to EGF that is in-
dependent of the Ras pathway and expression of Jun, Fos,
Slug, and Myc (5). In contrast, in PDGF-stimulated cells, the
target of the Src pathway is Myc (2). Because withdrawal
of FGF-1 did not affect either the Src kinase activity or the
high steady-state levels of Myc mRNA, we sought to deter-
mine whether Myc expression influences the migratory po-
tential of these cells. FR901228 is a fungal metabolite that is
used as an antitumor antibiotic (64). The ability of FR901228
to reverse the transformed morphology of Ha-ras-transfected
Ras-1 cells can be directly correlated with specific inhibition
of the presence of Myc mRNA. FR901228 treatment results
in a decrease in Myc protein levels, and neither affects the
steady-state levels of Ha-ras, b-actin, or Grb-2 mRNA (64
and Yufang Shi, personal communication) nor macromolec-
ular biosynthesis (64). Thus, quiescent Balb/c 3T3 cells were
treated with the Myc inhibitor FR901228 (64) in the presence
of FGF-1. Interestingly, we observed a marked decrease in
the migratory potential of the constant, transient, and de-
layed cell populations (Fig. 7 B). The Myc inhibitor also se-
verely decreased the proliferative response of the cells to
FGF-1 (data not shown). Thus, the function of Myc appears
to be critical for FGF-1 to induce cell migration in vitro.
Discussion
Earlier studies have demonstrated that withdrawal of
FGF-1 (71), PDGF, or EGF (67) during the prereplicative
period of the cell cycle results in attenuation in the level of
DNA synthesis. In this study we have extended this obser-The Journal of Cell Biology, Volume 141, 1998 1656
vation by studying the biochemical events following
growth factor withdrawal from the cell culture system dur-
ing the G1 period. We also demonstrated that removal of
FGF-1 is sufficient to reverse tyrosine phosphorylation of
FGFR-1 and the MAP kinase pathway, and that these bio-
chemical events correlate with an attenuation of FGF-
1–induced DNA synthesis. In contrast, transient exposure
to exogenous FGF-1 results in continual activation of the
FGF-1–induced Src pathway, including tyrosine phos-
phorylation of cortactin and changes in the cytoskeletal ar-
chitecture that correlate with an inability of growth factor
withdrawal to affect significantly the migratory potential
of the cell. The tyrosine kinase receptor–mediated Ras-
MAP kinase pathway, which includes activation of the
MAP kinases and expression of several nuclear proteins
including Fos (27) and Myc (30), has been shown to be es-
sential for cell proliferation. Recently, however, Barone
et al. demonstrated that in response to PDGF, the target
of the Src pathway is Myc, and the target of the Ras/MAP
kinase pathway is Fos in Balb/c 3T3 cells (2). Our results
are consistent with these observations, and suggest that in
response to FGF-1, Src may lead to high steady-state lev-
els of Myc mRNA. Furthermore, while the MAP kinase
pathway may play some role in Myc expression, dephos-
phorylation of p44mapk and p42mapk in response to FGF-1
withdrawal can be directly correlated with downregulation
of Fos expression. In contrast, Boyer et al. demonstrated
that activation of Src is required for EGF-induced disper-
sion of epithelial cells, and that this scattering is indepen-
dent of the Ras-MAP kinase pathway and immediate–
early gene activation, including Myc (5). Additionally,
mutation of the Src phosphorylation site in the PDGF re-
ceptor-b (Tyr934) results in an increase in PDGF-induced
migration and a decrease in the stimulation of DNA syn-
thesis in porcine aortic endothelial cells (31). Although
these results appear to contradict the results presented
here, it may be possible that these data reflect differences
in receptor tyrosine kinase signaling in different cell types,
as well as by different growth factors. Indeed, while FGF-1
is able to induce tyrosine phosphorylation of Src and cort-
actin and increase the steady-state levels of the Fos tran-
script in presenescent populations of human diploid um-
bilical vein endothelial cells (25), it is unable to induce
phosphorylation of Src and cortactin in senescent popula-
tions of human endothelial cells and presenescent and se-
nescent populations of human diploid IMR-90 fibroblasts.
However, the levels of Fos mRNA are increased in all cases
(26). These data further suggest that FGF-1–induced ex-
pression of Fos is not dependent on the Src pathway. Fur-
thermore, while nonproliferative senescent populations of
human umbilical vein endothelial cells respond to FGF-1
by inducing both immediate-early (Fos) and early (ODC)
transcripts, FGF-1 is unable to signal FGFR-1–mediated
tyrosine phosphorylation of Src and cell migration in se-
nescent populations of human endothelial cells (25). In ad-
dition, intracellular distribution of Src may also play a role
in the ability of Src to regulate cell migration since Src can
enhance fibroblast spreading derived from Src homozy-
gous null mice in a manner independent of its intrinsic ty-
rosine kinase activity, but dependent upon its ability to as-
sociate with focal adhesion plaques (41). Since Src is
known to associate with the focal adhesion kinase (FAK;
12, 15), and embryonic cells derived from FAK-deficient
mice demonstrate an impaired migratory potential (36), it
is also possible that the Tyr934 PDGF receptor-b mutant
may alter intracellular distribution of Src by an alternative
pathway involving PDGF-dependent association of Src
and FAK at adhesion sites. However, our data do support
a bifurcation of the FGF-1 signal transduction pathway in
which disparate intracellular signaling and transcriptional
events possibly regulate migratory and mitogenic cell fate.
Indeed, the rapid return of Fos expression, but not Myc or
ODC, to quiescent levels after FGF-1 withdrawal is consis-
tent with the observation that Myc is the target of the Src
Figure 7. (A) Migration of Balb/c 3T3 cells upon differential
FGF-1 stimulation. Confluent monolayers of Balb/c 3T3 cells
were wounded with a razor blade, and then stimulated with FGF-1
as described in Materials and Methods. Unstimulated cells were
used as a comparative control (C). The number of cells migrating
into the denuded area after a 22-h incubation at 378C was deter-
mined by counting using a microscope with a grid at 1003. Be-
cause the total number of migratory cells varied between experi-
ments, these data are the average of two independent
experiments, two plates each, and are normalized to the level of
total migration in the constantly-stimulated populations. Al-
though the total number of migratory cells varied among experi-
ments, the trends observed for the different populations were in-
deed consistent. (B) Migration of Balb/c 3T3 cells in the presence
or absence of the Myc inhibitor FR901228. Confluent monolayers
of quiescent Balb/c 3T3 cells were wounded and stimulated with
FGF-1 in the presence of 2.5 ng/ml FR901228 as described in Ma-
terials and Methods. The various cell populations were stimu-
lated in the absence of the inhibitor as a control.LaVallee et al. Regulation of FGF-1–induced Cell Migration and Proliferation 1657
pathway, and that Fos is the target of the Ras/MAPK
pathway (2) since (a) Src activity, (b) cortactin tyrosine
phosphorylation, (c) F-actin and cortactin redistribution,
and (d) Myc transcript levels are independent of FGF-1
withdrawal. Furthermore, inhibition of Myc expression se-
verely compromises the cells’ migratory potential. Al-
though we do not know the role of ODC expression, both
Src (53) and Myc (4, 23, 43) have been demonstrated to be
required for migration in other cell types. Recently,
Huang et al. demonstrated that Src-induced tyrosine phos-
phorylation of cortactin results in a decreased ability of
cortactin to cross-link actin (34), which may enhance the
migratory potential of the cells.
The requirement of extracellular FGF-1 during the G1
phase of the cell cycle for initiation of maximal DNA synthe-
sis may reflect a physiologic safeguard that allows cells to
discriminate between a sustained proliferative stimulus and
an occasional short-term contact with FGF-1, and thus pre-
vent inopportune proliferation that may lead to hyperpla-
sia and possibly tissue dysfunction. In contrast, sustained
proliferative stimulation afforded by FGF-1 may be pro-
vided in areas of wound repair and/or inflammation where
local conditions such as hypoxia, hyperthermia, and acido-
sis may result in the long-term presence of extracellular
FGF-1, and thus ensure that compensatory cell prolifera-
tion is provided in these areas (59). Indeed, the release of
FGF-1 as a signal peptide-less mitogen is very tightly regu-
lated (39, 62), and requires extended time periods for ac-
cumulation of significant levels of FGF-1 as a functional
extracellular protein (39). Therefore, the requirement that
cells be stimulated continually with FGF-1 throughout the
prereplicative period may be an additional mechanism
used to regulate the biological potency of this mitogen.
The FGF prototypes are involved in regulating biologic
events in which cell migration is an important component,
such as mesoderm formation, angiogenesis, neointima for-
mation, and neurotrophic repair (7, 22). Since many of
these biologic responses involve both cell migration and
proliferation, it is possible that intermittent exposure of
cells to extracellular FGF-1 may be used as a mechanism
solely to modify biologic activities associated with cell mi-
gration. Interestingly, FGF-1 is a potent inducer of neurite
outgrowth and neuronal repair (10). Since the mechanism
of neurite formation is not dependent upon cell prolifera-
tion and uses Src as an intracellular regulatory agent (11),
it is possible that in nonneuronal cells, short-term expo-
sure to FGF-1 may play a role in lamellipodia formation.
In confluent populations of cells, this possibility may ei-
ther lead to reorganization of the cytoskeleton without the
initiation of cell migration, or in the case of the endothelial
cell, the initiation of sprout formation (75).
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